Regeneron Pharmaceuticals, Inc.'s Diabetic Eye Remedy Drug Impresses In Phase 3 Trial

Two-Year Results From Phase 3 VISTA Trial of EYLEAA Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision TARRYTOWN, N.Y. /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VISTA-DME trial of EYLEAA Injection for the treatment of diabetic macular edema , ... (more)

http://ift.tt/1npIuhu